glp-1 shortage fda FDA's decision kicks off 'unprecedented' tussle over FDA ends GLP-1 shortage. Compounding
Description
Labs help identify risks and guide safe treatment

These 3.8 million met the clinical criteria for the Bridge program, did not have a diagnosis of type 2 diabetes, sleep apnea or MASH, did not have a GLP-1 Part D covered prescription in 2023 and "could be eligible for the Medicare GLP-1 Bridge, assuming no changes in diagnosis or GLP-1 use in Part D in 2026," the report added

But for the average consumer buying insurance through the marketplace or a small employer, the coverage simply vanished
(US), Celltrion Healthcare Co., Ltd

It is easy to treat "don't lose muscle" as a vanity concern, but on a GLP-1 it is a health and durability concern, and understanding why makes the protein-and-creatine priority click

Aerobic exercise did not change that ratio significantly
